Abstract:Background Alzheimer disease has no known cure. As existing pharmacologic interventions only modestly slow cognitive decline, there is a need for new treatments. Recent trials of repetitive transcranial magnetic stimulation (rTMS) have reported encouraging results for improving or stabilizing cognition in patients diagnosed with Alzheimer dementia. However, owing to small samples and lack of a well-controlled double-blind design, the results to date are inconclusive. This paper presents the protocol for a large placebo-controlled double-blind study designed with sufficient statistical rigor to measure the efficacy of rTMS treatment in patients with Alzheimer dementia. Objective The objectives are to (1) recruit and enroll up to 200 eligible participants, (2) estimate the difference in treatment effects between active treatment and sham treatment, (3) estimate the difference in treatment effects between two doses of rTMS applications, (4) estimate the duration of treatment effects among responders to active rTMS treatment, and (5) estimate the effect of dementia severity on treatment outcomes among patients receiving active rTMS treatment. Methods We have designed our study to be a double-blind, randomized, placebo-controlled clinical trial investigating the short- and long-term (up to 6 months) benefits of active rTMS treatment at two doses (10 sessions over 2 weeks and 20 sessions over 4 weeks) compared with sham rTMS treatment. The study will include patients aged ≥55 years who are diagnosed with Alzheimer disease at an early to moderate stage and have no history of seizures and no major depression. The primary outcome measure is the change in the Alzheimer Disease Assessment Scale-Cognitive Subscale score from pretreatment to posttreatment. Secondary outcomes are changes in performance on tests of frontal lobe functioning (Stroop test and verbal fluency), changes in neuropsychiatric symptoms (Neuropsychiatric Inventory Questionnaire), and changes in activities of daily living (Alzheimer Disease Co-operative Study-Activities of Daily Living Inventory). Tolerability of the intervention will be assessed using a modification of the Treatment Satisfaction Questionnaire for Medication. We assess participants at baseline and 3, 5, 8, 16, and 24 weeks after the intervention. Results As of November 1, 2020, we have screened 523 individuals, out of which 133 were eligible and have been enrolled. Out of the 133 individuals, 104 have completed the study. Moreover, as of November 1, 2020, there has been no serious adverse event. We anticipate that rTMS will considerably improve cognitive function, with effects lasting up to 3 months. Moreover, we expect rTMS to be a well-tolerated treatment with no serious side effect. Conclusions This protocol design will allow to address both the rTMS active treatment dose and its short- and long-term effects compared with sham treatment in large samples. Trial Registration ClinicalTrials.gov NCT02908815; https://clinicaltrials.gov/ct2/show/NCT02908815 International Registered Report Identifier (IRRID) DERR1-10.2196/25144

The Efficacy of COGnitive Training in Patients with Amnestic Mild Cognitive Impairment (COG-REAGENT): Protocol for a Multi-Center Randomized Controlled Trial.

Effect of cognitive training on episodic memory retrieval in amnestic mild cognitive impairment patients: study protocol for a clinical randomized controlled trial

Application of Cognitive Training Therapy for Alzheimer’s Disease and Evaluation of Its Efficacy

Repeated Transcranial Magnetic Stimulation for Improving Cognition in Patients With Alzheimer Disease: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial

Effect of home-based and remotely supervised combined exercise and cognitive intervention on older adults with mild cognitive impairment (COGITO): study protocol for a randomised controlled trial

Computerized Cognitive Training for Chinese Mild Cognitive Impairment Patients: A Neuropsychological and Fmri Study

Shanghai cognitive intervention of mild cognitive impairment for delaying progress with longitudinal evaluation-a prospective, randomized controlled study (SIMPLE): rationale, design, and methodology

The effects of 24‐week computerized cognitive training in patients with mild cognitive impairment and Alzheimer’s disease: A single‐blind controlled trial

Effects of Different Cognitive Trainings on Amnestic Mild Cognitive Impairment in the Elderly: A One-Year Longitudinal Functional Magnetic Resonance Imaging (MRI) Study.

Effects of visual-motor combined response ability training on cognitive function and brain plasticity mechanism in different populations: a study protocol for a single-center, open-label, controlled clinical trial

[P1–096]: MULTI‐MODEL COGNITIVE TRAINING FOR MILD COGNITIVE IMPAIRMENT PATIENTS: CLINICAL AND FUNCTIONAL NEUROIMAGING OUTCOMES FROM A PILOT STUDY

P3‐299: BASELINE POSTERIOR CINGULATE CORTEX‐MEDIAL TEMPORAL/HIPPOCAMPAL NETWORKS IN MCI PREDICTS THE EFFECT OF COGNITIVE TRAINING

The Effects of Multi-Domain Versus Single-Domain Cognitive Training in Non-Demented Older People: a Randomized Controlled Trial.

Effects of computerized cognitive training on structure‒function coupling and topology of multiple brain networks in people with mild cognitive impairment: a randomized controlled trial

Multidomain interventions for non-pharmacological enhancement (MINE) program in Chinese older adults with mild cognitive impairment: a multicenter randomized controlled trial protocol

Digital Computerised Cognitive Training for Preventing Cognitive Decline among Hypertensive Patients: a Study Protocol for a Multicentre Randomised Controlled Trial (DELIGHT Trial)

Effect of Multimodal Intervention in Individuals with Mild Cognitive Impairment: A Randomized Clinical Trial in Shanghai

Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial

Effectiveness of Computerized Cognitive Training in Delaying Cognitive Function Decline in People With Mild Cognitive Impairment: Systematic Review and Meta-analysis

Clinical Efficacy of Brain and Body Rehab Training (BBRT) Multi‐dimensional Cognitive Intervention Digital Therapeutic in Patients with Mild Cognitive Impairment: a Three‐arm, Randomized Controlled Trial

The Efficacy of Cognitive Training for Elderly Chinese Individuals with Mild Cognitive Impairment